Literature DB >> 16784493

Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.

J Vegh1, P Szodoray, J Kappelmayer, I Csipo, M Udvardy, G Lakos, M Aleksza, P Soltesz, A Szilágyi, M Zeher, G Szegedi, E Bodolay.   

Abstract

We investigated the clinical characteristics and immunoserological alterations in patients with mixed connective tissue disease (MCTD) associated with pulmonary arterial hypertension (PAH). Anti-U1RNP autoantibodies, anti-endothelial cell antibodies (AECA) and serum thrombomodulin (TM) as well as von Willebrand factor antigen (vWFAg) concentrations were measured in 25 patients with MCTD associated with PAH and in 154 MCTD patients without PAH. The results showed that the probability of survival was lower in MCTD patients with PAH than in the 154 MCTD-non-PAH patients (5-year survival rate in MCTD with PAH: 73%, versus 96% in MCTD-non-PAH; P < 0.01). AECA were more frequently present in the sera of MCTD patients with PAH than in MCTD-non-PAH (P < 0.001). Serum TM and vWFAg levels were higher in MCTD-PAH patients than in MCTD-non-PAH patients (TM: P < 0.001; vWFAg: P < 0.001). Significant correlation was noticed between the quantity of AECA and TM level (r = 0.466) as well as the quantity of AECA and vWFAg level (r = 0.550). In conclusion, our results suggest that in MCTD the presence of AECA and endothelial cell activation may play a role in the development of PAH and in the maintenance of obliterative vascular processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784493     DOI: 10.1111/j.1365-3083.2006.01770.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases.

Authors:  A V Hadjinicolaou; L Wu; B Fang; P A Watson; F C Hall; R Busch
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

2.  Successful laparoscopic Nissen fundoplication in a patient with mixed connective tissue disease with a short esophagus: report of a case.

Authors:  Kiyokazu Nakajima; Tsuyoshi Takahashi; Shuji Takiguchi; Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2013-09-10       Impact factor: 2.549

Review 3.  Pulmonary hypertension in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

4.  Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.

Authors:  Pal Soltesz; Daniel Bereczki; Peter Szodoray; Maria T Magyar; Henrietta Der; Istvan Csipo; Agota Hajas; Gyorgy Paragh; Gyula Szegedi; Edit Bodolay
Journal:  Arthritis Res Ther       Date:  2010-05-06       Impact factor: 5.156

5.  Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension.

Authors:  Caterina Naclerio; Salvatore D'Angelo; Silvano Baldi; Gianluigi Tagliamonte; Salvatore Scarpato
Journal:  Clin Rheumatol       Date:  2009-08-04       Impact factor: 2.980

6.  Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.

Authors:  Edit Bodolay; Zoltan Prohászka; Gyorgy Paragh; Istvan Csipő; Gabor Nagy; Renata Laczik; Nora Demeter; Eva Zöld; Britt Nakken; Gyula Szegedi; Peter Szodoray
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

7.  Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension.

Authors:  Moloud Rabieyousefi; Pejman Soroosh; Kimio Satoh; Fumiko Date; Naoto Ishii; Masahiro Yamashita; Masahiko Oka; Ivan F McMurtry; Hiroaki Shimokawa; Masato Nose; Kazuo Sugamura; Masao Ono
Journal:  BMC Immunol       Date:  2011-12-15       Impact factor: 3.615

Review 8.  Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.

Authors:  Balazs Odler; Vasile Foris; Anna Gungl; Veronika Müller; Paul M Hassoun; Grazyna Kwapiszewska; Horst Olschewski; Gabor Kovacs
Journal:  Front Physiol       Date:  2018-06-19       Impact factor: 4.566

Review 9.  Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases.

Authors:  Nicola Ciancio; Mauro Pavone; Sebastiano Emanuele Torrisi; Ada Vancheri; Domenico Sambataro; Stefano Palmucci; Carlo Vancheri; Fabiano Di Marco; Gianluca Sambataro
Journal:  Multidiscip Respir Med       Date:  2019-05-15

10.  Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria.

Authors:  Kevin John John; Mohammad Sadiq; Tina George; Karthik Gunasekaran; Nirmal Francis; Ebenezer Rajadurai; Thambu David Sudarsanam
Journal:  Int J Rheumatol       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.